World Scientific
Skip main navigation

Cookies Notification

We use cookies on this site to enhance your user experience. By continuing to browse the site, you consent to the use of our cookies. Learn More
×
Spring Sale: Get 35% off with a min. purchase of 2 titles. Use code SPRING35. Valid till 31st Mar 2025.

System Upgrade on Tue, May 28th, 2024 at 2am (EDT)

Existing users will be able to log into the site and access content. However, E-commerce and registration of new users may not be available for up to 12 hours.
For online purchase, please visit us again. Contact us at customercare@wspc.com for any enquiries.
https://doi.org/10.1142/9789813236318_0006Cited by:0 (Source: Crossref)
Abstract:

Computed tomography (CT) is the single most important imaging study in the evaluation of thoracic oncology patients. Current CT scanners allow for complete volumetric imaging of the chest during a single breath hold and with a low radiation dose. Chest CT is commonly ordered to further assess an abnormality detected on a chest radiograph. Chest CT is also commonly ordered without a preceding chest radiograph when a patient’s presenting symptoms are acute, severe, or confer a sufficiently high pretest probability for malignant or non-malignant disease. The National Lung Screening Trial (NLST) has demonstrated that low-dose Chest CT can be used to screen for lung cancer in high-risk patients resulting in a reduction in overall and lung cancer mortality. Lung cancer screening will be covered in a dedicated section later in this text…